DENALI THERAPEUTICS INC's ticker is DNLI and the CUSIP is 24823R105. A total of 188 filers reported holding DENALI THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 2.00 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $14,029,994 | -30.7% | 680,078 | -0.9% | 0.01% | -28.6% |
| Q2 2023 | $20,258,385 | +79.8% | 686,492 | +40.4% | 0.01% | +75.0% |
| Q1 2023 | $11,265,662 | -23.1% | 488,961 | -7.1% | 0.01% | -27.3% |
| Q4 2022 | $14,640,825 | -12.6% | 526,459 | -3.6% | 0.01% | -15.4% |
| Q3 2022 | $16,753,000 | +112.6% | 545,871 | +103.9% | 0.01% | +116.7% |
| Q2 2022 | $7,879,000 | -8.9% | 267,732 | -0.5% | 0.01% | +20.0% |
| Q1 2022 | $8,653,000 | -41.3% | 269,004 | -18.6% | 0.01% | -44.4% |
| Q4 2021 | $14,730,000 | -3.9% | 330,275 | +8.7% | 0.01% | -10.0% |
| Q3 2021 | $15,328,000 | -40.7% | 303,827 | -7.7% | 0.01% | -41.2% |
| Q2 2021 | $25,834,000 | +34.0% | 329,344 | -2.4% | 0.02% | +21.4% |
| Q1 2021 | $19,275,000 | +10.9% | 337,567 | +62.7% | 0.01% | +7.7% |
| Q4 2020 | $17,381,000 | +139.5% | 207,504 | +2.4% | 0.01% | +116.7% |
| Q3 2020 | $7,257,000 | +48.6% | 202,545 | +0.3% | 0.01% | +50.0% |
| Q2 2020 | $4,885,000 | +36.6% | 202,022 | -1.1% | 0.00% | 0.0% |
| Q1 2020 | $3,576,000 | -8.7% | 204,253 | -9.2% | 0.00% | +33.3% |
| Q4 2019 | $3,918,000 | +16.9% | 224,909 | +2.8% | 0.00% | 0.0% |
| Q3 2019 | $3,351,000 | -26.7% | 218,763 | -0.6% | 0.00% | -25.0% |
| Q2 2019 | $4,570,000 | +5.4% | 220,117 | +17.9% | 0.00% | 0.0% |
| Q1 2019 | $4,337,000 | +12.9% | 186,760 | +0.4% | 0.00% | 0.0% |
| Q4 2018 | $3,842,000 | -5.0% | 185,950 | -0.0% | 0.00% | 0.0% |
| Q3 2018 | $4,043,000 | +45.1% | 185,967 | +1.8% | 0.00% | +33.3% |
| Q2 2018 | $2,786,000 | +9.8% | 182,720 | +41.8% | 0.00% | +50.0% |
| Q1 2018 | $2,538,000 | -10.2% | 128,900 | -28.7% | 0.00% | -33.3% |
| Q4 2017 | $2,827,000 | – | 180,769 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Crestline Management, LP | 19,462,500 | $339,037,000 | 35.95% |
| Euclidean Capital LLC | 323,749 | $27,117,000 | 5.74% |
| Flagship Pioneering Inc. | 2,730,263 | $228,687,000 | 4.16% |
| Casdin Capital, LLC | 1,310,000 | $109,726,000 | 3.25% |
| A.R.T. Advisors, LLC | 6,173 | $517,000 | 2.39% |
| MARK ASSET MANAGEMENT LP | 172,040 | $14,410,000 | 1.73% |
| Temasek Holdings (Private) Ltd | 4,410,457 | $369,420,000 | 1.59% |
| Integral Health Asset Management, LLC | 57,500 | $4,816,000 | 1.43% |
| GILDER GAGNON HOWE & CO LLC | 3,219,843 | $269,694,000 | 1.34% |
| IRONWOOD INVESTMENT MANAGEMENT LLC | 19,365 | $1,622,000 | 0.95% |